Genetec (4492.T) Stock Price
Genetec Price
Over the last 7 years Genetec grew revenue by 10.6% annually, reaching 8.12 B JPY. Earnings per share have grown at 3.8% per year over the last 7 years. For Genetec, the net margin of 5.2% is broadly stable versus 4.3% a few years ago. At today's price the dividend yield works out to roughly 4.50%. The payout ratio is around 50% of earnings. The dividend has grown at 98.6% per year over the past 5 years. The stock trades about 15% above its 52-week low.
Genetec stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Genetec over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Genetec stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Genetec's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Genetec Price |
|---|---|
| 9/18/2026 | 400.00 JPY |
| 9/17/2026 | 400.00 JPY |
| 9/16/2026 | 393.00 JPY |
| 9/15/2026 | 399.00 JPY |
| 9/14/2026 | 401.00 JPY |
| 9/11/2026 | 402.00 JPY |
| 9/10/2026 | 402.00 JPY |
| 9/9/2026 | 396.00 JPY |
| 9/8/2026 | 393.00 JPY |
| 9/7/2026 | 398.00 JPY |
| 9/4/2026 | 396.00 JPY |
| 9/3/2026 | 411.00 JPY |
| 9/2/2026 | 392.00 JPY |
| 9/1/2026 | 390.00 JPY |
| 8/31/2026 | 403.00 JPY |
| 8/28/2026 | 378.00 JPY |
| 8/27/2026 | 378.00 JPY |
| 8/26/2026 | 375.00 JPY |
| 8/25/2026 | 370.00 JPY |
| 8/24/2026 | 365.00 JPY |
| 8/21/2026 | 373.00 JPY |
| 8/20/2026 | 375.00 JPY |
| 8/19/2026 | 380.00 JPY |
| 8/18/2026 | 383.00 JPY |
| 8/17/2026 | 381.00 JPY |
| 8/14/2026 | 384.00 JPY |
| 8/13/2026 | 392.00 JPY |
| 8/12/2026 | 385.00 JPY |
| 8/10/2026 | 381.00 JPY |
| 8/7/2026 | 375.00 JPY |
Genetec Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Genetec Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB JPY |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB JPY |
| EBITM JPY |
| EBIT MARGIN% |
| NET INCOMEM JPY |
| NET INCOME GROWTH% |
| DIVIDENDDIV.JPY |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e |
|---|---|---|---|---|---|---|---|---|
| 4.00 | 4.48 | 4.72 | 4.08 | 4.68 | 5.86 | 7.15 | 8.12 | 7.21 |
| – | 11.94 | 5.31 | -13.58 | 14.81 | 25.22 | 21.88 | 13.67 | -11.26 |
| 32.62 | 33.67 | 34.09 | 38.27 | 41.90 | 39.51 | 40.69 | 40.26 | 40.26 |
| 1.31 | 1.51 | 1.61 | 1.56 | 1.96 | 2.32 | 2.91 | 3.27 | 2.90 |
| 127.00 | 259.00 | 335.00 | 254.00 | 190.00 | 105.00 | 629.00 | 693.00 | 358.00 |
| 3.17 | 5.78 | 7.10 | 6.23 | 4.06 | 1.79 | 8.80 | 8.53 | 4.97 |
| 83.00 | 179.00 | 212.00 | 173.00 | 56.00 | 23.00 | 414.00 | 421.00 | 260.00 |
| – | 115.66 | 18.44 | -18.40 | -67.63 | -58.93 | 1,700.00 | 1.69 | -38.24 |
| – | – | 0.58 | 1.17 | 3.33 | 6.67 | 22.50 | 18.00 | 32.00 |
| – | – | – | 101.72 | 184.62 | 100.30 | 237.33 | -20.00 | 77.78 |
| 2.99 | 2.99 | 3.16 | 11.31 | 11.45 | 11.50 | 11.59 | 11.62 | 11.62 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Genetec generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Genetec retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Genetec's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Genetec has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Genetec's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Genetec stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Genetec Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Genetec business model & stock analysis
Genetec Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Genetec historical P/E ratio, EBIT multiple, and P/S ratio
Genetec annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down Genetec's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in Genetec's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare Genetec's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Genetec shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Genetec stock splits
Since 2021, a total of 6 shares have been converted from one Genetec share.
Genetec Dividend History
7 years of dividend payments
Genetec dividend history and estimates
Max
Details
Genetec dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Genetec Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 2/13/2025 | -JPY | 2.20JPY | 2.02 BJPY | - | 2024 Q4 |
| 8/10/2023 | -JPY | -5.26JPY | 2.54 BJPY | - | 2023 Q2 |
| 5/15/2023 | -JPY | 54.36JPY | 2.54 BJPY | - | 2023 Q1 |
| 2/14/2023 | -JPY | -13.46JPY | 2.54 BJPY | - | 2022 Q4 |
Genetec shareholder structure
| % | Name |
|---|---|
35.53367% | |
9.64535% | |
5.21739% | |
4.60870% | |
4.45013% | |
3.82182% |
Genetec Beneficial Ownership Filings (SEC 13D/G)
Genetec Executives and Management Board
13 members · avg. age 59 · 15 % women
Management
Mr. Kenji Ueno (74)
President, Executive President, Representative Director · since 1985
Mr. Akihiro Suzuki (62)
Senior Managing Executive Officer, Senior Director of Business Management and Administration · since 2021
Mr. Tsukasa Suenaga (66)
Senior Managing Executive Officer, Director · since 2025
Mr. Koichi Kakubuchi (64)
Managing Executive Officer, Director of Engineering Solutions Business · since 2023
Ms. Chiai Matsuno (55)
Managing Executive Officer, Director of System Business · since 2023
Mr. Takashi Ogawa
Managing Executive Officer
Board of Directors
Mr. Masatoshi Hachinohe (61)
Director · since 2015
Ms. Midori Mizutani (44)
Independent Director
Mr. Hiroyoshi Shirakami (64)
Independent Director
Mr. Shunpei Tanaka (63)
Independent Director
Genetec Supply Chain
Genetec Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.39 | -0.27 | -0.58 | ||
| 2 | -0.35 | -0.49 | -0.47 | ||
| 3 | 0.43 | -0.35 | -0.47 |
Frequently asked questions about Genetec
Converted at the current exchange rate, the Genetec share trades at 2.22 EUR (400.00 JPY).
No history available for Genetec.
The expected revenue of Genetec is 7.21 B JPY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Genetec is 260.41 M JPY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Genetec is currently 17.85. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Genetec stock.
The price-to-sales ratio (P/S) of Genetec is currently 0.64. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Genetec stock.
The Eulerpool Quality Score for Genetec is 3/10.
The ISIN of Genetec is JP3428000008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Genetec is 4492.T. The ticker symbol is used to trade Genetec shares on the stock exchange.
Over the past 12 months, Genetec paid a dividend of 18.00 JPY . This corresponds to a dividend yield of about 4.50 %. For the coming 12 months, Genetec is expected to pay a dividend of 22.50 JPY.
The current dividend yield of Genetec is 4.50 %.
Genetec pays a dividend, distributed in the months of September, March.
Genetec paid dividends every year for the past 6 years.
For the upcoming 12 months, dividends amounting to 22.50 JPY are expected. This corresponds to a dividend yield of 5.63 %.
Genetec is assigned to the 'Information technology' sector.
To receive the latest dividend of Genetec from 6/1/2026 amounting to 14 JPY, you needed to have the stock in your portfolio before the ex-date on 3/30/2026.
The last dividend was paid out on 6/1/2026.
In the year 2025, Genetec distributed 18 JPY as dividends.
The dividends of Genetec are distributed in JPY.
Genetec stock
Genetec Peer Group
Genetec FIGI
All fundamentals and in-depth analysis of Genetec
Our stock analysis for Genetec stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genetec. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.